Did AstraZeneca announce Cansino Biologics Inc ( 6185 HK) Stock?

AstraZeneca did not have an immediate comment on the announcement. Find the latest CanSino Biologics Inc. (6185.HK) stock quote, history, news and other vital information to help you with your stock trading and investing.

What is Cansino biologics?

CANSINO BIOLOGICS INC. CanSino Biologics Inc is a clinical-stage vaccine company in China. The Company's products include Ad5-EBOV vaccine used for Ebola virus, MCV2 and MCV4 vaccines for meningococcus, PBPV vaccine used for pneumococcal and the recombinant novel coronavirus vaccine.

What is China’s Cansino bio?

China's CanSino Bio is the first in the world to advance a COVID-19 vaccine into phase 2 testing. (CanSino) In the global race to develop an effective vaccine to protect people against the novel coronavirus, China’s CanSino Bio has leapt ahead.

Why did cansinobio's share price fall?

U.S. federal health agencies recommended on Tuesday that use of a similar one-shot vaccine from Johnson & Johnson (JNJ.N) be paused after six women developed rare blood clots. CanSinoBIO's shares fell as much as 13.7% and 18.4% in Shanghai and Hong Kong respectively.